BMJ Surgery, Interventions, & Health Technologies (Dec 2024)

Initial experience of parenchyma-sparing liver resection with systematic selective hepatic vein reconstruction for colorectal metastases

  • Yevhenii Trehub,
  • Åsmund Avdem Fretland,
  • Artem Zelinskyi,
  • Dzmitrii Kharkov,
  • Oleksii Babashev,
  • Dmytro Chieverdiuk,
  • Artem Shchebetun,
  • Kyrylo Khyzhniak,
  • Maksym Pavlovskii,
  • Andrii Strokan,
  • Sergii Zemskov

DOI
https://doi.org/10.1136/bmjsit-2024-000302
Journal volume & issue
Vol. 6, no. 1

Abstract

Read online

Objectives This study aims to assess the feasibility and short-term and intermediate-term technical success rate of the concept of systematic selective hepatic vein (HV) reconstruction for parenchyma-sparing hepatectomies (PSHs) in patients with colorectal liver metastases (CRLM) in accordance with stage 2a of the IDEAL framework.Design The prospective case series of patients deemed eligible and operated on according to the concept.Setting All patients were treated by a single surgical team in three hospitals in Ukraine from June 2022 to November 2023.Participants The study included nine cases of resectable CRLM with at least one lesion located in the hepatocaval confluence with HV(s) invasion, for whom reconstruction of the HV(s) allowed for additional parenchyma preservation, being an alternative to major or extended hepatectomy.Interventions Liver resections with different types of HVs reconstruction (primary closure, patching, end-to-end anastomosis with or without grafting) were performed after a thorough evaluation of the future liver remnant volume, volume of potentially additionally preserved parenchyma and possibility of future repeat hepatectomies.Main outcome measures Postoperative morbidity, short-term and long-term patency of the reconstructed vessels, and the volume of additionally preserved parenchyma were the focus.Results Segmental resection was performed in four cases, two with graft interposition. Patch reconstruction was performed for three HVs and two inferior vena cava resections. Two cases required primary closure. No mortality was observed, while the major morbidity rate was 33%. The short-term and long-term patency of the reconstructed HVs was 88.9% and 66.7%, respectively. HV reconstructions allowed the preservation of additional parenchyma (mean 495.4 mL, 95% CI 350.2 to 640.7). A decision-making algorithm to be used within the described approach is proposed.Conclusions Selective HV reconstruction is a feasible approach for PSH for CRLM. Further studies are needed to compare this approach to convenient major hepatectomies.